Aspen Neuroscience, Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

—

Shs. 5Y

—

Rev. 5Y

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.

Key people

Faheem Hasnain

Chairman of the Board

Damien Mcdevitt

President, Chief Executive Officer, Director

Kameel Farag

Chief Financial Officer

Andres Bratt-Leal

Co-Founder, Senior Vice President - Research and Development

Edward Wirth

Chief Medical Officer

URL

https://www.aspenneuroscience.com/

IPO date

Employees

Domiciled in

Incorporated in

Valuation

No data to show